- Tytuł:
- Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial
- Autorzy:
- Źródło:
- In Lung Cancer November 2023 185
Czasopismo naukowe